SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking precision medicine system developed by biotech trailblazer Diag-Nose.io hopes to transform the management of chronic respiratory diseases ...
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking precision medicine system developed by biotech trailblazer Diag-Nose.io is set to transform the management of chronic respiratory ...
(MENAFN- GlobeNewsWire - Nasdaq) Diag-Nose.io, a Stanford EENT Innovation graduate, secures $2M in oversubscribed seed funding to revolutionize respiratory care with precise, AI-driven diagnostics and ...
The MarketWatch News Department was not involved in the creation of this content. Diag-Nose.io, Graduate of CDL-Seattle, Closes Oversubscribed $2M Seed Round to Transform Respiratory Care with ...
A graduate of Creative Destruction Lab's 2023 class for Digital Health in Seattle, Diag-Nose.io is pioneering advancements in respiratory healthcare by focusing on the "unified airway”: the biological ...